Sign in

You're signed outSign in or to get full access.

Sarah Cogan

About Sarah E. Cogan

Sarah E. Cogan (born 1956) is an Independent Trustee of PIMCO Municipal Income Fund II (PML) and has served since 2019; she is standing for re‑election by Preferred Shareholders as a Class II Trustee, with a term running to the annual meeting held during the 2028 fiscal year if re‑elected . A retired partner of Simpson Thacher & Bartlett LLP (1989–2018), she led the firm’s registered funds practice and brings extensive investment company board oversight experience; she currently oversees 24 portfolios within the PIMCO‑managed fund complex and serves on multiple board committees .

Past Roles

OrganizationRoleTenureCommittees/Impact
Simpson Thacher & Bartlett LLPPartner; former head of registered funds practice1989–2018Led registered funds practice; extensive experience advising independent trustees and fund boards

External Roles

OrganizationRoleTenureNotes
Girl Scouts of Greater New York, Inc.DirectorSince 2016Non-profit governance role
Natural Resources Defense Council, Inc.TrusteeSince 2013Non-profit governance role
Allianz FundsTrustee2019–2021Investment company directorship (prior)
Virtus FundsTrustee2021–PresentInvestment company directorship (current)

Board Governance

  • Independent status: Cogan is an Independent Trustee; PML’s eight-member board has a supermajority of Independent Trustees (~75%), with an Independent Chair (Deborah A. DeCotis) .
  • Committee assignments: Audit Oversight Committee (member), Governance & Nominating Committee (member), Valuation Oversight Committee (member), Contracts Committee (Chair), Performance Committee (member) .
  • Election mechanics: Her re‑election is voted on exclusively by Preferred Shareholders; if re‑elected, the term runs to the annual meeting in the 2028 fiscal year .
  • Attendance and engagement: In FY 2024, the Board held 4 regular and 3 special meetings; committees met 3–4 times each. Every Trustee attended at least 75% of applicable Board and committee meetings .
  • Independent sessions and counsel: Independent Trustees regularly meet outside management’s presence and are advised by independent legal counsel .

Fixed Compensation

ComponentAmountSource/Notes
Base annual retainer (Independent Trustees)$275,000Fixed cash, payable quarterly
Contracts Committee Chair fee$30,000Fixed cash, payable quarterly
Total compensation from Funds and Fund Complex (CY 2024)$305,000Base + chair fees (matches published total)
Aggregate compensation from PML (FY ended Dec 31, 2024)$12,338Fund-level allocation

Independent Trustee pay is cash retainer with supplemental chair stipends; Trustees receive no pension or retirement benefits from the Funds or the fund complex .

Performance Compensation

Metric/InstrumentDisclosure StatusNotes
Annual/Discretionary bonusNot disclosedProxy outlines fixed retainer structure; no bonus disclosure for Independent Trustees
Equity awards (RSUs/PSUs/DSUs)Not disclosedNo equity award disclosure for Independent Trustees
Stock optionsNot disclosedNo option award disclosure for Independent Trustees
Performance metrics tied to director payNot disclosedIndependent Trustees compensated via fixed retainers; no performance linkage disclosed
Clawback provisions (director pay)Not disclosedNo clawback terms disclosed for Independent Trustee compensation

Other Directorships & Interlocks

Company/ComplexRoleDatesPotential Interlock/Notes
Virtus FundsTrustee2021–PresentInvestment company governance; independent role
Allianz FundsTrustee2019–2021Investment company governance; prior role

Expertise & Qualifications

  • Legal expertise: 25+ years as corporate partner at Simpson Thacher, including leadership of registered funds practice; extensive experience with investment company boards and counsel to Independent Trustees (including certain PIMCO‑Managed Funds) .
  • Fund oversight credentials: Serves on multiple oversight committees (Audit, Valuation, Governance), Chairs Contracts Committee; experienced in reviewing advisory, administrative, and distribution agreements .
  • Portfolio oversight scale: Oversees 24 portfolios in the Fund Complex, supporting breadth of investment company oversight .

Equity Ownership

HolderDollar Range of Equity Securities in the FundsAggregate Dollar Range in Family of Investment Companies
Sarah E. CoganOver $100,000Over $100,000

To the Funds’ knowledge as of the Record Date, Independent Trustees did not knowingly own beneficially securities of an investment adviser or principal underwriter of the Funds or persons controlling them (other than registered investment companies) .

Governance Assessment

  • Board effectiveness: Cogan’s committee breadth (Audit, Governance, Valuation, Performance) and chairing of the Contracts Committee support robust oversight of fees, valuation, and manager performance—key controls for closed‑end funds .
  • Independence and alignment: Independent status, independent-majority board, and independent counsel are positive governance features; her “Over $100,000” fund holdings indicate personal financial alignment with shareholders .
  • Compensation structure: Fixed cash retainer plus chair stipend (no disclosed equity/options/bonuses) limits pay-for-performance signaling but reduces misalignment risk typical of equity-heavy structures for directors; total 2024 compensation of $305,000 reflects base plus chair fee .
  • Attendance/engagement: Board and committees met frequently in 2024 and Trustees met ≥75% participation thresholds, supporting engagement .
  • Potential conflicts/RED FLAGS:
    • Prior role as counsel to Independent Trustees of certain PIMCO‑Managed Funds could be perceived as familiarity risk, though she is classified as independent under the 1940 Act and NYSE audit committee standards .
    • Classified board and “Continuing Trustee” provisions may entrench board composition and raise thresholds for certain corporate actions, potentially limiting shareholder influence; preferred shareholders vote separately on her re‑election .
  • No related-party transactions, hedging/pledging, or say‑on‑pay outcomes are disclosed in the proxy for Independent Trustees; absence of disclosure limits assessment of those risk indicators .